Results 121 to 130 of about 872,130 (197)

Blood Groups and Susceptibility to Hepatitis C Virus Infection Among β- Thalassaemia Patients

open access: yesDiyala Journal of Medicine, 2018
Background: Blood groups have revealed associations with a variety of diseases. However, most of these studies concerned general population and only few of them the potential relationship with viral hepatitis.
Najdat Shukur Mahmood
doaj   +2 more sources

Beta Thalassemia and Chronic Myeloid Leukemia: Dual Diagnosis Under the Microscope

open access: yes
International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 931-933, October 2026.
Paige Muir   +3 more
wiley   +1 more source

Inherited microcytic anemias due to disorders of iron and heme metabolism: An updated clinical review

open access: yesHemaSphere, Volume 10, Issue 9, September 2026.
Abstract Microcytic anemia is among the most common hematological abnormalities in clinical practice and is usually attributable to iron deficiency, thalassemia traits, or anemia of inflammation. A small but clinically important subset of patients, however, has inherited disorders of iron metabolism or heme synthesis presenting with persistent ...
Alexandros Makis   +2 more
wiley   +1 more source

The development and validation of a patient based health outcome measure for adults with beta thalassaemia major (BTM) [PDF]

open access: yes, 2010
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.For the astract, please see the PDF ...
Kantaris, Xenya
core   +1 more source

Academic Performance Among Children With Sickle Cell Disease in Low‐ and Middle‐Income Countries: A Systematic Review

open access: yesHealth Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aim Children with sickle cell disease (SCD) in low‐ and middle‐income countries (LMICs) face significant disease‐related challenges and socioeconomic status (SES) disparities that may negatively impact their academic performance. This systematic review synthesized existing evidence on academic performance among children with SCD
Shubaya K. Naggayi   +7 more
wiley   +1 more source

Contemporary Management of Thalassemia: A Perspective on Current Standards and the Emergence of FDA‐Approved Oral Therapy

open access: yesHealth Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Thalassemia is an inherited hemoglobin disorder characterized by ineffective erythropoiesis, chronic anemia, and progressive multisystem complications that require lifelong management. Current treatment relies on regular red blood cell transfusions, iron chelation therapy, and supportive multidisciplinary care, while ...
Fnu Zainab   +3 more
wiley   +1 more source

Sickle Cell Disease and Kidney Injury: Circulating Uromodulin Allows Early Tissue Specific Diagnosis and Monitoring of Treatment

open access: yes
American Journal of Hematology, Volume 101, Issue 9, Page 2430-2434, September 2026.
Ferras Alashkar   +10 more
wiley   +1 more source

Genome Editing for Glycogen Storage Diseases

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 5, September 2026.
ABSTRACT Gene therapy has been developed for several glycogen storage diseases and has advanced into clinical trials. However, the limitations of these gene therapies with regard to stability following treatment early in life have led to the development of genome editing.
Troy von Beck   +2 more
wiley   +1 more source

Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE. [PDF]

open access: yesDrugs Context, 2022
Tran NT   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy